Literature DB >> 1659800

Involvement of glycoprotein C (gC) in adsorption of herpes simplex virus type 1 (HSV-1) to the cell.

B Svennerholm1, S Jeansson, A Vahlne, E Lycke.   

Abstract

Results demonstrating involvement of glycoprotein C (gC) of herpes simplex type 1 virus (HSV-1) in attachment of the virus to the cell are presented. Monoclonal antibodies against gC-1 inhibited adsorption of gC(+)-strains. The gC(-)-mutant, MP, attached to cells but at a reduced rate. Attachment of the MP-mutant was unaffected by presence of anti-gC-1 antibody. Purified truncated gC-1 adsorbed to cells at a rate essentially the same as that of gC(+)-virus. Glycoprotein C-1 pretreated with heparin did not adsorb to cells. The results are compatible with a suggested role for gC in HSV attachment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659800     DOI: 10.1007/bf01310482

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor.

Authors:  N Langeland; H Holmsen; J R Lillehaug; L Haarr
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Initial interaction of herpes simplex virus with cells is binding to heparan sulfate.

Authors:  D WuDunn; P G Spear
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity.

Authors:  P J Desai; P A Schaffer; A C Minson
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

4.  Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus.

Authors:  T C Mettenleiter; L Zsak; F Zuckermann; N Sugg; H Kern; T Ben-Porat
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

5.  Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface.

Authors:  J E Kühn; M D Kramer; W Willenbacher; U Wieland; E U Lorentzen; R W Braun
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Glycoprotein C-dependent attachment of herpes simplex virus to susceptible cells leading to productive infection.

Authors:  G Campadelli-Fiume; D Stirpe; A Boscaro; E Avitabile; L Foá-Tomasi; D Barker; B Roizman
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

7.  Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoproteins.

Authors:  D Sawitzky; H Hampl; K O Habermehl
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

8.  Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1.

Authors:  R J Kaner; A Baird; A Mansukhani; C Basilico; B D Summers; R Z Florkiewicz; D P Hajjar
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

9.  Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes.

Authors:  A Vahlne; B Svennerholm; E Lycke
Journal:  J Gen Virol       Date:  1979-07       Impact factor: 3.891

10.  A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells.

Authors:  M W Ligas; D C Johnson
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  24 in total

Review 1.  Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.

Authors:  D Shukla; P G Spear
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host cell adhesion.

Authors:  Na Zhang; Jinghua Yan; Guangwen Lu; Zhengfei Guo; Zheng Fan; Jiawei Wang; Yi Shi; Jianxun Qi; George F Gao
Journal:  Nat Commun       Date:  2011-12-06       Impact factor: 14.919

3.  Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.

Authors:  Tina M Cairns; Zhen-Yu Huang; J Charles Whitbeck; Manuel Ponce de Leon; Huan Lou; Anna Wald; Claude Krummenacher; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

4.  Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo.

Authors:  R E Herrold; A Marchini; S Fruehling; R Longnecker
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.

Authors:  Tina M Cairns; Zhen-Yu Huang; John R Gallagher; Yixin Lin; Huan Lou; J Charles Whitbeck; Anna Wald; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

6.  Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin.

Authors:  M T Shieh; P G Spear
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.

Authors:  Linda Mark; David G Proctor; David J Blackbourn; Anna M Blom; O Brad Spiller
Journal:  Immunology       Date:  2007-08-30       Impact factor: 7.397

8.  The Importance of Heparan Sulfate in Herpesvirus Infection.

Authors:  Christopher D O'Donnell; Deepak Shukla
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

9.  Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.

Authors:  B C Herold; S I Gerber; B J Belval; A M Siston; N Shulman
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.

Authors:  H P Huemer; C Larcher; M P Dierich; D Falke
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.